One68 Global Capital LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

One68 Global Capital LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 3,000 shares of the healthcare conglomerate's stock, valued at approximately $1,518,000. UnitedHealth Group makes up approximately 0.8% of One68 Global Capital LLC's portfolio, making the stock its 29th largest holding.

A number of other hedge funds have also recently modified their holdings of UNH. Howard Capital Management Group LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $341,000. Principal Financial Group Inc. raised its stake in UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after buying an additional 180,479 shares during the last quarter. McIlrath & Eck LLC grew its holdings in shares of UnitedHealth Group by 8.2% in the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock worth $371,000 after acquiring an additional 48 shares during the period. SOA Wealth Advisors LLC. increased its position in shares of UnitedHealth Group by 3.7% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock valued at $746,000 after purchasing an additional 46 shares during the last quarter. Finally, Tudor Financial Inc. purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth $900,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 2.8 %

NYSE:UNH traded down $11.37 during mid-day trading on Thursday, hitting $400.07. 9,289,533 shares of the company's stock traded hands, compared to its average volume of 4,571,255. UnitedHealth Group Incorporated has a twelve month low of $399.53 and a twelve month high of $630.73. The company has a market capitalization of $364.15 billion, a P/E ratio of 25.81, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a fifty day moving average of $497.29 and a 200 day moving average of $529.82.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the company posted $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Morgan Stanley lowered their price target on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.